EWS/FLI Is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-17-0182
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Therapeutic Opportunities in Ewing Sarcoma: EWS-FLI Inhibition via LSD1 Targeting

Oncotarget
Oncology
2016English

PDGF-C Is an EWS/FLI Induced Transforming Growth Factor in Ewing Family Tumors

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

DNA-binding and Transcriptional Activation Properties of the EWS-FLI-1 Fusion Protein Resulting From the T(11;22) Translocation in Ewing Sarcoma.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1994English

EWS-FLI1 Regulates a Transcriptional Program in Cooperation With Foxq1 in Mouse Ewing Sarcoma

Cancer Science
Cancer ResearchMedicineOncology
2018English

18f-FLT Positron Emission Tomography (PET) Is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma

Scientific Reports
Multidisciplinary
2016English

Genomic EWS-FLI1 Fusion Sequences in Ewing Sarcoma Resemble Breakpoint Characteristics of Immature Lymphoid Malignancies

PLoS ONE
Multidisciplinary
2013English

Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming

Cancer Cell
Cancer ResearchOncologyCell Biology
2013English

Transcription Factor RD26 Is a Key Regulator of Metabolic Reprogramming During Dark-Induced Senescence

New Phytologist
Plant SciencePhysiology
2018English

Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy